Table Graph
      published meta-analysis   sensitivity analysis   studies

Hydrocortisone in COVID-19 severe or critically - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsREMAP-CAP, fixed 7-day course, 2020 1.03 [0.54; 1.98] 1.03[0.54; 1.98]REMAP-CAP, fixed 7-day course, 202010%236NAnot evaluable deathsdetailed resultsREMAP-CAP, fixed 7-day course, 2020 0.94 [0.61; 1.45] 0.94[0.61; 1.45]REMAP-CAP, fixed 7-day course, 202010%238NAnot evaluable deaths (time to event analysis only)detailed resultsREMAP-CAP, fixed 7-day course, 2020 0.94 [0.61; 1.45] 0.94[0.61; 1.45]REMAP-CAP, fixed 7-day course, 202010%238NAnot evaluable clinical improvementdetailed resultsREMAP-CAP, fixed 7-day course, 2020 1.43 [0.91; 2.26] 1.43[0.91; 2.26]REMAP-CAP, fixed 7-day course, 202010%278NAnot evaluable clinical improvement (14-day)detailed resultsREMAP-CAP, fixed 7-day course, 2020 1.29 [0.82; 2.03] 1.29[0.82; 2.03]REMAP-CAP, fixed 7-day course, 202010%238NAnot evaluable death or ventilationdetailed resultsREMAP-CAP, fixed 7-day course, 2020 2.74 [1.16; 6.46] 2.74[1.16; 6.46]REMAP-CAP, fixed 7-day course, 202010%98NAnot evaluable serious adverse eventsdetailed resultsREMAP-CAP, fixed 7-day course, 2020 3.01 [0.33; 27.32] 3.01[0.33; 27.32]REMAP-CAP, fixed 7-day course, 202010%238NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-05-12 09:19 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 91 - treatments: 737 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons